Date published: 2025-9-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

Statine (CAS 49642-07-1)

0.0(0)
Write a reviewAsk a question

Alternate Names:
(3S,4S)-4-Amino-3-hydroxy-6-methylheptanoic acid
CAS Number:
49642-07-1
Molecular Weight:
175.23
Molecular Formula:
C8H17NO3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Statine is a chemical compound that functions as a competitive inhibitor of the enzyme HMG-CoA reductase. It plays a role in blocking the conversion of HMG-CoA to mevalonate, a key step in the biosynthesis of cholesterol. By inhibiting this enzyme, statine disrupts the production of cholesterol in cells, ultimately leading to a decrease in cholesterol levels. Statine targets the active site of HMG-CoA reductase, preventing the enzyme from carrying out its catalytic function. As a result, statine interferes with the normal cellular processes involved in cholesterol synthesis. This mode of action at the molecular level makes statine a useful substance for studying the regulation of cholesterol metabolism and its potential impact on cellular function.


Statine (CAS 49642-07-1) References

  1. An Improved Enantiospecific Synthesis of Statine and Statine Analogs via 4-(N,N-Dibenzylamino)-3-keto Esters.  |  Hoffman, RV. and Tao, J. 1997. J Org Chem. 62: 2292-2297. PMID: 11671547
  2. Design of rat renin inhibitory peptides.  |  Hui, KY., et al. 1988. J Med Chem. 31: 1679-86. PMID: 3045320
  3. Inhibition of cathepsin D by substrate analogues containing statine and by analogues of pepstatin.  |  Agarwal, NS. and Rich, DH. 1986. J Med Chem. 29: 2519-24. PMID: 3783611
  4. Synthesis of all the stereoisomers of statine (4-amino-3-hydroxy-6-methylheptanoic acid). Inhibition of pepsin activity by N-carbobenzoxy-L-valyl-L-valyl-statine derived from the four stereoisomers.  |  Liu, WS., et al. 1979. J Med Chem. 22: 577-9. PMID: 379333
  5. Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analogue inhibitor.  |  Rich, DH. 1985. J Med Chem. 28: 263-73. PMID: 3882966
  6. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.  |  Boger, J., et al. 1985. J Med Chem. 28: 1779-90. PMID: 3906131
  7. Novel renin inhibitors containing the amino acid statine.  |  Boger, J., et al. Nature. 303: 81-4. PMID: 6341856
  8. The Stereoselective Synthesis of threo-3-Hydroxy-4-amino Acids  |  Katsuki, T., & Yamaguchi, M. 1976. Bulletin of the Chemical Society of Japan. 49(11): 3287-3290.
  9. Synthesis of 4-amino-3-hydroxy-6-methylheptanoic acid by a modified Reformatsky reaction  |  Liu, W. S., & Glover, G. I. 1978. The Journal of Organic Chemistry. 43(4): 754-755.
  10. A short and efficient synthesis of (3S,4S)-4-[(tert-Butyloxycarbonyl)amino]-5-cyclohexyl-3-hydroxypentanoic acid ethyl ester  |  Schuda, P. F., Greenlee, W. J., Chakravarty, P. K., & Eskola, P. 1988. The Journal of Organic Chemistry. 53(4): 873-875.
  11. Highly stereocontrolled synthesis of the four individual stereoisomers of statine  |  Kano, S., Yuasa, Y., Yokomatsu, T., & Shibuya, S. 1988. The Journal of Organic Chemistry. 53(16): 3865-3868.
  12. Enantioselective and diastereoselective formation of syn-3-hydroxy-4-amino acids (syn-statines) via tetramic acids  |  Schmidt, U., Riedl, B., Haas, G., Griesser, H., Vetter, A., & Weinbrenner, S. 1993. Synthesis. 1993(02): 216-220.
  13. A facile synthesis of N-protected statine and analogs via a lipase-catalyzed kinetic resolution  |  Baenziger, M., McGarrity, J. F., & Meul, T. 1993. The Journal of Organic Chemistry. 58(15): 4010-4012.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Statine, 50 mg

sc-296421
50 mg
$291.00

Statine, 250 mg

sc-296421A
250 mg
$1170.00